| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/02/1985 | EP0139501A2 The manufacture and expression of genes for thaumatin |
| 05/02/1985 | EP0139417A1 Vaccines based on membrane bound proteins and process for making them |
| 05/02/1985 | EP0139416A2 Molecularly cloned diagnostic product and method of use |
| 05/02/1985 | EP0139383A1 Method for expressing foreign genes in schizosaccharomyces pombe and the use in therapeutic formulations of the products, DNA constructs and transformant strains of schizosaccharomyces pombe usable in such method and their preparation |
| 05/02/1985 | EP0139216A2 Adult T cell leukemia virus antigen peptide |
| 05/02/1985 | EP0139201A1 Diagnostic method and kit |
| 05/02/1985 | EP0139076A2 Human-parathyroid hormone (human-PTH) producing hybrid vector |
| 04/30/1985 | US4514498 Urogential disorders |
| 04/30/1985 | US4514391 Hypotensive agents; analgesics |
| 04/30/1985 | US4514387 Chemokinesins and chemotaxins of leukocytes and inflamed tissues |
| 04/30/1985 | US4514331 Peptide hormones with calcitonin-like activity |
| 04/30/1985 | CA1186223A1 Isolation of principal outer membrane protein and antigen of chlamydia trachomatis |
| 04/25/1985 | WO1985001746A1 The manufacture and expression of genes for thaumatin |
| 04/25/1985 | WO1985001659A1 Monoclonal antibodies against endotoxin of gram-negative bacteria |
| 04/25/1985 | WO1985001658A1 Human calcitonin-gene-related-peptide |
| 04/24/1985 | EP0138704A2 Hepatitis A-subunit antigen |
| 04/24/1985 | EP0138667A2 Method for the diagnosis of lymphadenopathy and acquired immune depression syndrome |
| 04/24/1985 | EP0138644A1 Novel plasmid vectors |
| 04/24/1985 | EP0138616A2 Nona- and dodecapeptides for augmenting natural killer cell activity, processes for making them and pharmaceutical compositions comprising them |
| 04/24/1985 | EP0138604A2 Arginine vasopressin antagonists |
| 04/24/1985 | EP0138437A2 Novel hybrid regulatory region |
| 04/24/1985 | EP0138416A2 Growth hormone release factor analogs |
| 04/24/1985 | EP0138385A2 Hydrophilic biopolymeric copolyelectrolytes, and biodegradable wound dressings comprising same |
| 04/24/1985 | EP0138377A1 Lewis blood group phenotype assay |
| 04/24/1985 | EP0138242A1 Method of preparing DNA complementary to the genome of coronaviruses |
| 04/24/1985 | EP0138222A2 Preparation of monoclonal anti-protein C antibodies |
| 04/24/1985 | EP0138167A1 Method for purification of HBs antigen |
| 04/24/1985 | EP0138133A1 cDNA clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity and/or mast cell growth factor activity |
| 04/24/1985 | EP0138101A1 Genetically engineered organisms expressing surface proteins of T. Cruzi |
| 04/24/1985 | EP0138087A1 Immune interferon and method for its purification |
| 04/24/1985 | EP0137904A2 Biologically active peptides structurally related to regions within growth hormones |
| 04/24/1985 | EP0137869A2 Derived nisin producing microorganisms, method of production and use and products obtained thereby |
| 04/24/1985 | EP0137822A1 Specific antibody to the native form of 2'5'-oligonucleotides, the method of preparation and the use as reagents in immunoassays or for binding 2'5'-oligonucleotides in biological systems. |
| 04/23/1985 | US4513083 Staphylocidin from rothia dentocariosa |
| 04/23/1985 | US4512988 Acylamino oxo or hydroxy substituted alkylamino thiazines and thiazepines |
| 04/23/1985 | US4512974 Administering leukocyte endogenous mediator |
| 04/23/1985 | US4512971 Mitogens of leukocytes and inflamed tissues |
| 04/23/1985 | US4512970 Chemorecruitins of leukocytes and inflamed tissues |
| 04/23/1985 | US4512923 Luteinizing and follicle stimulating hormones and process for the preparation thereof |
| 04/17/1985 | EP0137691A1 Production of immune interferon and its mRNA |
| 04/17/1985 | EP0137689A1 GRF analogs |
| 04/17/1985 | EP0137657A2 Monoclonal antibodies |
| 04/17/1985 | EP0137633A1 Method of expressing alpha-1-antitrypsin in bacteria and its use in therapeutic formulations, and vectors and bacteria for such method and their production |
| 04/17/1985 | EP0137457A2 Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules |
| 04/17/1985 | EP0137361A2 Insulin derivatives modified in position B 30, process for their preparation, their vuse and pharmaceutical agents for the treatment of diabetes mellitus |
| 04/17/1985 | EP0137345A2 Membrane-associated proteins (MP-2), process for obtaining them and their application |
| 04/17/1985 | EP0137339A1 Pharmacologically active peptides |
| 04/17/1985 | EP0137234A2 Physiologically active compositions |
| 04/17/1985 | EP0137221A2 Process for separating lipoproteins bv means of derived polyhydroxymethylene |
| 04/16/1985 | US4511653 Process for the industrial preparation of collagenous materials from human placental tissues, human collagenous materials obtained and their application as biomaterials |
| 04/16/1985 | US4511652 High efficiency eukaryotic metallothionein promoter system |
| 04/16/1985 | US4511505 Threonine derivatives |
| 04/16/1985 | US4511504 Collagenase inhibitors |
| 04/11/1985 | WO1985001517A1 PRODUCTION OF cDNA REPRESENTING HEPATITIS A VIRAL SEQUENCES |
| 04/11/1985 | WO1985001516A1 Vectors for the expression of an antigenic protein of rabies in eucaryotic cells and application thereof to the preparation of a vaccine |
| 04/11/1985 | WO1985001515A1 T-cell growth factor of the gibbon ape |
| 04/10/1985 | EP0136947A2 Conjugated lipopolysaccharides, process for their preparation and their use as immunizing agents |
| 04/10/1985 | EP0136938A2 Derivatives of furanes, their preparation and application |
| 04/10/1985 | EP0136932A2 Method and materials for development of immunological responses protective against malarial infection |
| 04/10/1985 | EP0136835A2 Process for the preparation of antibody compositions of therapeutic agents having an extended serum half-life |
| 04/10/1985 | EP0136829A2 Improved expression vector and use thereof |
| 04/10/1985 | EP0136792A2 Neocarzinostatin derivatives and a process for manufacturing the same |
| 04/10/1985 | EP0136791A2 Neocarzinostatin derivatives and method of producing the same |
| 04/10/1985 | EP0136728A2 Process for the dissolution of peptides and proteins, solutions thereby obtained and their use |
| 04/10/1985 | EP0136694A2 Production of monomeric human gamma-interferon |
| 04/10/1985 | EP0136620A1 Homogeneous immune interferon fragment |
| 04/10/1985 | EP0136490A2 DNA plasmids |
| 04/10/1985 | EP0136489A1 Analogs of human interleukin II and their preparation |
| 04/10/1985 | EP0136475A2 Novel growth hormone-releasing peptides and method of treating mammals therewith |
| 04/10/1985 | EP0136472A1 Production of secretin |
| 04/10/1985 | EP0136375A1 A regulatory glycoprotein for immune response in the production of T-cell growth factor |
| 04/10/1985 | EP0136334A1 Method for producing very pure albumin and for depyrogenating albumin-containing starting substances |
| 04/10/1985 | EP0020780B1 Fibrinolytic material and process for producing same |
| 04/09/1985 | US4510245 Yeast expression vector; genetic engineering |
| 04/09/1985 | US4510084 Using plasma to form complex, adsorptton on ion exchanger, separation, and lyophilization |
| 04/09/1985 | CA1185180A1 Peptides as medicament and certain novel peptides |
| 04/09/1985 | CA1185178A1 Method for purifying interferon |
| 04/03/1985 | EP0136215A2 Method and materials for development of immunological responses protective against malarial infection |
| 04/03/1985 | EP0136093A2 Anti-cancer factors |
| 04/03/1985 | EP0136090A2 Improvements in or relating to expression plasmids |
| 04/03/1985 | EP0136053A2 Preparation of proliferation inhibitors |
| 04/03/1985 | EP0135841A2 Herpes simplex virus subunit vaccine |
| 04/03/1985 | EP0135797A2 Process for preparing lymphotoxin and lymphotoxin-mRNA |
| 04/03/1985 | EP0135722A2 Peptides having an immunostimulating effect, process for their preparation and their use |
| 04/03/1985 | EP0135720A2 Process for the preparation of insuline derivatives |
| 04/03/1985 | EP0135712A2 Antigens and monoclonal antibodies reactive against sporozoites of eimeria spp. |
| 04/03/1985 | EP0135592A1 Dna synthesis-repressing substance |
| 04/02/1985 | US4508833 Separation of interleukin-2 from phytohemagglutinin by dye matrix chromatography |
| 04/02/1985 | US4508826 Bacteriophage DNA cloning vector TG1 and microorganisms containing TG1 |
| 04/02/1985 | US4508712 Atrial peptide |
| 04/02/1985 | US4508711 Animal growth regulator |
| 04/02/1985 | US4508709 Adsorption, elution form aminohexyl agarose |
| 04/02/1985 | US4508644 Quantitative determination of enzymes |
| 04/02/1985 | US4508643 Human chorionic govadotropin; low cross-reactivity |
| 04/02/1985 | CA1184899A1 Glycoprotein |
| 04/02/1985 | CA1184862A1 Filtration method for cell produced antiviral substances |
| 03/28/1985 | WO1985001298A1 Monoclonal anti-interleukin-2 antibody useful for immunopurification for interleukin-2 |
| 03/28/1985 | WO1985001292A1 Pharmacologically active peptides |
| 03/28/1985 | WO1985001284A1 Synthetic peptides with egf like activity and pharmaceutical compositions and methods of use |
| 03/27/1985 | EP0135435A2 Immunogenic HBsAg derived from transformed yeast |